Unlocking challenging targets for structure-guided drug development
PUXANO is trusted by pharmaceutical and biotech leaders worldwide to drive structure-based protein research, enabling breakthroughs in vaccine and antibody development and small-molecule drug screening.
Our key mission is to make challenging targets accessible via a powerful discovery platform that seamlessly integrates in silico protein design with advanced nanotechnological and biotechnological tools for in-depth experimental research.
The PROCONDOR platform
PUXANO has developed a proprietary technology platform which fuses biotechnology, nanotechnology, and AI to revolutionize protein design and structure-based research to get access to those challenging targets where standard workflows fail.
We hereby use a multi-layered approach that is specifically tailored to target proteins such as outer membrane proteins, glycoproteins, GPCRs, ion channels and fragile protein complexes.
We have build a protein design toolbox for generating soluble analogues, multimer-stabilizing scaffolds, multi-epitope scaffolds, multimer-generating scaffolds or fiducials to build antigens for vaccine and antibody development, facilitate high-throughput drug screening or accelerate structure-guided drug development.
Via our cryoEM grid portfolio, we can overcome major problems in cryoEM sample preparation: low sample yields, complex dissassembly or preferred particle orientation. Furthermore, this enables to gain access to proteins isolated from patient-derived samples in a reproducible efficient manner.
Our research and platform technologies are trusted by top pharmaceutical and biotechnology companies and research centres worldwide. We can proudly state that we have accelerated drug discovery pipelines of targets that were blocked in the past and we thrive in making the impossible possible.
Organisations we work with
Access to the PUXANO grid portfolio
Standard grid types, such as our graphene grids, can be purchased directly from us or from distributors as boxes of 20 grids.
Your trusted partner
At PUXANO, we begin by thoroughly analyzing your protein target to design a customized workflow tailored to your needs. Our Design-to-Structure or Gene-to-Structure workflows encompass every critical step.
Our focus areas include vaccine development, antibody development, and small-molecule drug screening of the most challenging targets.
To streamline collaboration, we offer three types of framework agreements, designed to match your project’s scope, timeline, and objectives. Whether you’re exploring new targets or scaling up discovery efforts, our flexible partnerships ensure seamless integration with your research and development goals.
27 May 2026
Events
11 June 2026
Events
